Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eplerenone in Cyclosporine A-treated Kidney Transplant Recipients
NCT01834768Phase 2Unknown
- Sponsor
- CHU de Reims
- Start
- Feb 2013
- Primary completion
- Apr 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of eplerenone in nephrotoxicity, sponsored by CHU de Reims. Primary endpoint: Occurrence of an adverse event requiring the discontinuation of eplerenone at 8 weeks. Status: unknown.
02
Drugs
eplerenone
03
Conditions
nephrotoxicity
Beyond the preview
Go deeper on NCT01834768.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01834768.